Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Geetabali, Sircar"'
Publikováno v:
Journal of Clinical Rheumatology and Immunology, Vol 24, Iss supp01, Pp 111-111 (2024)
Introduction: Acute Pancreatitis in systemic lupus Erythematous is rare but has high mortality. Incidence varies from 1-5% and reported mortality is 3-37.04% with mortality being higher in juvenile SLE. Objective: Study of Clinical and serological pr
Externí odkaz:
https://doaj.org/article/0f390ba384ae49ff8f149c6d589d082d
Autor:
Kaustav Chowdhury, Uma Kumar, Soumabha Das, Jaydeep Chaudhuri, Prabin Kumar, Maumita Kanjilal, Parashar Ghosh, Geetabali Sircar, Ravi Kiran Basyal, Uma Kanga, Santu Bandyopadhaya, Dipendra Kumar Mitra
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-12 (2018)
Abstract Background Role of Th9 cells and interleukin-9 (IL-9) in human autoimmune diseases such as psoriasis and ulcerative colitis has been explored only very recently. However, their involvement in human rheumatoid arthritis (RA) is not conclusive
Externí odkaz:
https://doaj.org/article/9fea8a4c5c6f4fe6975de083ae35e14e
Autor:
Sonali Dey, Rashmi Roongta, Sumantro Mondal, Subhankar Haldar, Geetabali Sircar, Biswadip Ghosh, Alakendu Ghosh
Publikováno v:
Lupus. 31:1132-1137
Introduction: Macrophage Activation Syndrome (MAS) is a rare but potentially fatal complication in rheumatic diseases. Here, we report the case of a 14-year-old girl with MAS as the primary manifestation of Systemic Lupus Erythematosus (SLE). She had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39db2e646ddd3179fe0f8df4eb2f080e
https://doi.org/10.1177/09612033221108852
https://doi.org/10.1177/09612033221108852
Autor:
Sumit Sen, Pradyot Sinhamahapatra, Supriyo Choudhury, Anusree Gangopadhyay, Sanchaita Bala, Geetabali Sircar, Gobinda Chatterjee, Alakendu Ghosh
Publikováno v:
Indian Journal of Dermatology, Vol 59, Iss 1, Pp 35-40 (2014)
Context: Mixed connective tissue disorder is an uncommon disease. Some scientists are reluctant to recognize it as a separate entity. Some others have defined this ailment. Cutaneous features of this condition are unique. Researchers from India have
Externí odkaz:
https://doaj.org/article/6764915f3da54074875cea24e57660fc
Autor:
Parasar Ghosh, Geetabali Sircar, Animesh Ray, Moumita Chatterjee, Rudra Prosad Goswami, Arindam Mukherjee
Publikováno v:
Rheumatology. 60:557-567
Objectives To assess the effect of rituximab (RTX) on the lung function parameters in SSc interstitial lung disease (SSc-ILD) patients. Methods PubMed and Embase were searched to identify studies on SSc-ILD treated with RTX, confined to a predefined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a0d99d9407fafe61ef0c4b34236075
https://doi.org/10.1093/rheumatology/keaa550
https://doi.org/10.1093/rheumatology/keaa550
Autor:
Sumantro Mondal, MavidiS Kumar, Geetabali Sircar, Sudipta Ghorai, Subhankar Haldar, Alakendu Ghosh
Publikováno v:
Indian Journal of Nephrology. 33:132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c1fe5383dcc13944e12183922d867d7
https://doi.org/10.4103/ijn.ijn_414_21
https://doi.org/10.4103/ijn.ijn_414_21
Autor:
Alakendu Ghosh, Parasar Ghosh, Debasish Lahiri, Arpita Hati, Geetabali Sircar, Debanjali Sinha, Rudra Prosad Goswami, Sumantro Mondal
Publikováno v:
Mediterranean Journal of Rheumatology. 33:421
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38255172cdd65a6bc35d852263251cc9
https://doi.org/10.31138/mjr.33.4.421
https://doi.org/10.31138/mjr.33.4.421
Autor:
Rudra Prosad Goswami, Sumantro Mondal, Debanjali Sinha, Geetabali Sircar, Parasar Ghosh, Alakendu Ghosh
Publikováno v:
Indian Journal of Rheumatology, Vol 12, Iss 1, Pp 52-53 (2017)
Externí odkaz:
https://doaj.org/article/710bfcce0e0f4060b9c08790a81bcab0
Publikováno v:
Rheumatology International. 39:1351-1358
The objective is to assess quality-of-life (QoL) parameters among Indian female systemic lupus erythematosus (SLE) patients with durable remission. Indian female SLE patients in remission determined by the European consensus criteria and age-matched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926b9545ed98e1e5bbeeda76ba65582d
https://doi.org/10.1007/s00296-019-04329-1
https://doi.org/10.1007/s00296-019-04329-1
Autor:
Roopkatha Bhattacharya, Amrit Raj Ghosh, Parasar Ghosh, Dipyaman Ganguly, Geetabali Sircar, Oindrila Rahaman, Chinky Shiu Chen Liu, Deblina Raychaudhuri, Rudra Prasad Goswami, Santu Pal, Purbita Bandopadhyay
Publikováno v:
The Journal of Immunology. 202:1674-1679
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, characterized by loss of tolerance toward self nuclear Ags. Systemic induction of type I IFNs plays a pivotal role in SLE, a major source of type I IFNs being the plasmacytoid dendr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f6838a5d1a45d576063a20dfbd270e
https://doi.org/10.4049/jimmunol.1801521
https://doi.org/10.4049/jimmunol.1801521